Philips North America vs TAKEDA PHARMACEUTICALS U.S.A., INC.: FDA Enforcement Comparison

Philips North America has been the subject of 355 FDA enforcement/approval records tracked by Argus HQ, compared to 1 for TAKEDA PHARMACEUTICALS U.S.A., INC..

Philips North America: 0 warning letters, 355 recalls, 0 approval records, 0 Form 483s.

TAKEDA PHARMACEUTICALS U.S.A., INC.: 0 warning letters, 0 recalls, 1 approval record, 0 Form 483s.

Side by side

Philips North America — Warning letters0

TAKEDA PHARMACEUTICALS U.S.A., INC. — Warning letters0

Philips North America — Recalls355

TAKEDA PHARMACEUTICALS U.S.A., INC. — Recalls0

Philips North America — Approval records0

TAKEDA PHARMACEUTICALS U.S.A., INC. — Approval records1

Philips North America — Form 483s0

TAKEDA PHARMACEUTICALS U.S.A., INC. — Form 483s0

Timeline

Philips North America

Most recent FDA action: July 1, 2026

Full history →

TAKEDA PHARMACEUTICALS U.S.A., INC.

Most recent FDA action: August 28, 2026

Full history →

Cite this comparison

Pre-formatted for a story, footnote, or reference list:

"Philips North America vs TAKEDA PHARMACEUTICALS U.S.A., INC.: FDA Enforcement Comparison." Argus HQ, accessed September 8, 2026. https://argushq.ai/compare/philips-north-america-vs-takeda-pharmaceuticals-u-s-a-inc

Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗